IFNB1 and Alzheimer disease: Furthermore, pretreatment with low doses of TLR4 agonists has been shown to stimulate microglia to produce neuroprotective cytokines, including IFN‐β, which could be considered a potential strategy to combat neuronal degeneration in AD (Yousefi et al. 2019).